These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 5081601)

  • 1. Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics.
    Nissenson AR; Levin NW; Parker RH
    Clin Pharmacol Ther; 1972; 13(6):887-94. PubMed ID: 5081601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity].
    Brogard JM; Ruscher H; Frankhauser J; Kuntzmann F; Lavillaureix J
    Pathol Biol (Paris); 1973 Jun; 21(6):671-9. PubMed ID: 4581199
    [No Abstract]   [Full Text] [Related]  

  • 3. [The elimination of the antibiotic cephacetrile in patients with impaired renal function].
    Spring P; Räber J; Reber H; Dettli L
    Arzneimittelforschung; 1974 Sep; 24(9b):1462-6. PubMed ID: 4479803
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics].
    Nissenson AR; Levin NW; Parker RH
    Arzneimittelforschung; 1974 Sep; 24(9b):1470-3. PubMed ID: 4479806
    [No Abstract]   [Full Text] [Related]  

  • 5. [The course of serum levels of a new cephalosporin, cephacetrile, as a function of renal elimination capacity].
    Brogard JM; Ruscher H; Frankhauser J; Kuntzmann F; Lavillaureix J
    Arzneimittelforschung; 1974 Sep; 24(9b):1491-7. PubMed ID: 4479810
    [No Abstract]   [Full Text] [Related]  

  • 6. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance].
    Malandain H; Humbert G; Fillastre JP; Acar J; Dubois D; Leroy J; Robert M; Daufresne MF
    Pathol Biol (Paris); 1973 Mar; 21(3):233-9. PubMed ID: 4574486
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.
    Westenfelder SR; Naber KG; Madsen PO
    Infection; 1973; 1(3):157-62. PubMed ID: 4597098
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacology of cephalexin administered intravenously.
    De Maine JB; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1970; 10():190-4. PubMed ID: 5521336
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
    Leroy A; Canonne MA; Fillastre JP; Humbert G
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasmatic half-life of a new cephalosporin in a patient with chronic renal insufficiency].
    Humbert G; Malandain H; Acar J; Fillastre JP
    Nouv Presse Med; 1972 May; 1(21):1438. PubMed ID: 5036700
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum half-lives and elimination rates of a new semi-synthetic cephalosporin, cephacetrile, in nephrectomized patients and in patients with impaired or normal renal function.
    Reutter F; Maurice NP
    Arzneimittelforschung; 1974 Sep; 24(9b):1466-8. PubMed ID: 4479804
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis.
    Ohkawa M; Tokunaga S; Sugata T; Shimamura M; Okasho A; Hirano S; Matsui H
    Chemotherapy; 1989; 35(6):416-22. PubMed ID: 2612231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.
    Westenfelder SR; Naber KG; Madsen PO
    Arzneimittelforschung; 1974 Sep; 24(9b):1481-5. PubMed ID: 4479808
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibacterial activity, pharmacokinetics and clinical use of a new cephalosporin antibiotic cephacetrile].
    Brogard JM; Kuntzmann F; Lavillaureix J
    Arzneimittelforschung; 1974 Sep; 24(9b):1528-33. PubMed ID: 4479819
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of cephacetrile in patients undergoing haemodialysis.
    Dominguez-Gil A; Lanao JM; Tabernero JM; Rodriguez Commes JL; de Castro S
    Eur J Clin Pharmacol; 1979 Aug; 16(1):49-52. PubMed ID: 499300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose furosemide (Lasix) in renal insufficiency.
    Seedat YK
    S Afr Med J; 1972 Sep; 46(38):1371-4. PubMed ID: 4638226
    [No Abstract]   [Full Text] [Related]  

  • 17. The serum half-life and urine concentrations of cephazolin sodium in patients with terminal renal failure: effect of haemodialysis.
    Eastwood JB; Gower PE; Curtis JR
    Scott Med J; 1976 Sep; 20(5):240-3. PubMed ID: 1265473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of intravenous Cefradin in normal and restricted renal function (author's transl)].
    Höffler D; Koeppe P
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1169-74. PubMed ID: 808712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood levels of cephalosporin in patients with chronic kidney insufficiency and with or without hemodialysis].
    Lobuseva AN; Fomina IP; Vasiliev VK; Levitskiĭ ER; Sagalovich OM
    Antibiotiki; 1972 Mar; 17(3):277-80. PubMed ID: 5030782
    [No Abstract]   [Full Text] [Related]  

  • 20. [Timing and dose in renal replacement therapy].
    Nalesso F; Giuliani A; Basso F; Brendolan A; Ronco C
    Cir Cir; 2013; 81(3):177-80. PubMed ID: 23769244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.